Page last updated: 2024-10-17

3,4-dihydroxyphenylacetic acid and Dominant Hereditary Sensory Neuropathy, Type III

3,4-dihydroxyphenylacetic acid has been researched along with Dominant Hereditary Sensory Neuropathy, Type III in 1 studies

3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.

Research Excerpts

ExcerptRelevanceReference
"This study tested whether familial dysautonomia (FD) involves progressive loss of noradrenergic nerves."1.35Plasma catechols in familial dysautonomia: a long-term follow-up study. ( Axelrod, FB; Goldstein, DS; Holmes, C, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goldstein, DS1
Holmes, C1
Axelrod, FB1

Other Studies

1 other study available for 3,4-dihydroxyphenylacetic acid and Dominant Hereditary Sensory Neuropathy, Type III

ArticleYear
Plasma catechols in familial dysautonomia: a long-term follow-up study.
    Neurochemical research, 2008, Volume: 33, Issue:9

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Dihydroxyphenylalanine; Dopamine; Dysautonomia, Familial; Epi

2008